News & Press Releases
Filter by:
Inside the Strategy 2 Mintz Attorneys Used to Strike a Mass. Rent Control Initiative From the November Ballot
August 6, 2026
Elissa Flynn-Poppey and Edmund Daley discussed with Law.com the legal strategy behind their successful challenge to a proposed Massachusetts rent control ballot initiative. Their argument that the measure's religious exemption violated Article 48 of the Massachusetts Constitution ultimately led to the initiative's removal from the November 2026 ballot.
Michelle Capezza’s insights were featured in a Fiduciary News article examining whether increasing retirement plan contribution limits would translate into greater retirement benefits for rank-and-file employees. The article explored the factors plan sponsors must consider when evaluating potential plan design changes.
Mintz Advises on $200 Million Private Placement Concurrent with Vidya Therapeutics’ and Processa Pharmaceuticals’ Merger Transaction
August 04, 2026
Mintz advised the placement agents on the $200 Million private placement in connection with Processa Pharmaceuticals, Inc.’s acquisition of Vidya Therapeutics, Inc.
Mintz Adds Former ITC Senior Attorney-Advisor to IP Practice, Further Strengthening Life Sciences and Innovation Capabilities
August 04, 2026
WASHINGTON, DC – Mintz is pleased to welcome Michael Leib, former senior attorney-advisor to multiple commissioners at the US International Trade Commission (ITC), to the firm's Intellectual Property Practice as a Member in its Washington, DC, office.
Has Canada’s Biotech Moment Finally Arrived?
August 4, 2026
Cheryl Reicin was quoted in The Globe and Mail discussing the resurgence of the biotechnology sector and the opportunities it presents for Canadian life sciences companies.
Mintz advised the placement agents in connection with LB Pharmaceuticals’ $150 Million private placement of common stock and pre-funded warrants.
